US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake of Donald Trump’s election for a second term as President.Read More

You might also be interested in reading BlackRock’s Spot Bitcoin ETF Not The Same As Grayscale’s Product, Experts Say.